Skip to search formSkip to main contentSkip to account menu

Haemophilus influenzae B Ab:MCnc:Pt:Ser:Qn

Known as: Haemophilus influenzae B Ab:KütlKons:Zml?:Ser:Kant, Haem influ B Ac Ser-mCnc, Haem influ B Ab Ser-mCnc 
National Institutes of Health

Papers overview

Semantic Scholar uses AI to extract papers important to this topic.
2009
2009
OBJECTIVE. New vaccines that offer protection against otitis media caused by nontypeable Haemophilus influenzae and by Moraxella… 
Review
2006
Review
2006
OBJECTIVE. Before 1991, Alaska Native children experienced one of the highest rates of invasive Haemophilus influenzae type b… 
2005
2005
BACKGROUND The generalization of the vaccination against H. influenzae b (Hib), according to its integration in the French… 
1991
1991
OBJECTIVE To evaluate the immunologic potential of infants 7 to 15 months of age to respond to Haemophilus influenzae type b… 
1987
1987
Induction of surface Mac-1 by inflammatory stimuli is fundamental to a broad spectrum of granulocyte adherence reactions. To… 
1987
1987
Twenty-six healthy children previously immunized (imm) with the Hib capsular polysaccharide (Hib CP) vaccine at age 19 to 38 mos… 
Highly Cited
1985
Highly Cited
1985
Hemophilus influenzae type b (HIB) is the leading cause of bacterial meningitis in the United States. Efforts are under way to… 
Highly Cited
1984
Highly Cited
1984
A long-term follow-up of approximately 50,000 children who received the Hemophilus influenzae type b capsular polysaccharide… 
1977
1977
An intranasal immunization with a A/PR8/34-isolated NA, protected mice as well as the whole virus and A/Hong Kong/1/68 virus…